Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Cerus Corporation (NasdaqNM:CERS)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
2411 Stanwell Drive
Concord, CA 94520
Phone: (925) 288-6000
Email: ir@ceruscorp.com
Employees (last reported count): 154
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 47%
·Over the last 6 months:
 · one insider buy; 35.0K shares (0.5% of insider shares)
 · 5 insider sells; 39.0K shares
  (0.5% of insider shares)
·Institutional: 33% (62% of float)
(111 institutions)
·Net Inst. Buying: 65.0K shares (+1.24%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Cerus Corporation is developing medical systems and therapeutics based on the Company's proprietary Helinx technology for inactivating disease-causing agents. The Company's most advanced programs are focused on systems to inactivate viruses, bacteria and other pathogens in platelets, fresh frozen plasma and red blood cells intended for transfusion. The Company's technology has potential applications in the health care field beyond pathogen inactivation in blood components. The Company has collaboration agreements with Baxter Healthcare Corporation, the Pharmaceutical Division of Kirin Brewery Co., Ltd. and the Consortium for Plasma Science.
More from Market Guide: Expanded Business Description

Financial Summary
Cerus Corp. is developing medical products based on a platform technology that prevents nucleic acid (DNA and RNA) replication, allowing for the development of systems to inactivate viruses, bacteria and other pathogens in blood components. For the six months ended 6/01, revenues totalled $3 million, up from $1.2 million. Net loss rose 45% to $23.1 million. Revenues reflect increased development agreements and government grants. Higher loss reflects increased R&D expenditures.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

B. Cassin, 67
Chairman
--  --  
Stephen Isaacs, 52
Pres, CEO
$420K--  
Gregory Schafer, 36
CFO, VP-Fin.
196K$90K
John Hearst, Ph.D., 65
VP- New Science Opportunities
262K--  
James Vaughn, 38
VP of Marketing
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CERSAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$31.688
Recent Price$53.82 
52-Week High
on 29-Dec-2000
$81.875
Beta0.62 
Daily Volume (3-month avg)116.8K
Daily Volume (10-day avg)186.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+9.8%
52-Week Change
relative to S&P500
+47.4%
Share-Related Items
Market Capitalization$845.7M
Shares Outstanding15.7M
Float8.30M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$8.84 
Earnings (ttm)-$3.06 
Earnings (mrq)-$0.80 
Sales (ttm)$0.26 
Cash (mrq)$9.89 
Valuation Ratios
Price/Book (mrq)6.09 
Price/EarningsN/A 
Price/Sales (ttm)205.31 
Income Statements
Sales (ttm)$3.69M
EBITDA (ttm)-$47.2M
Income available to common (ttm)-$43.2M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-44.35%
Return on Equity (ttm)-54.11%
Financial Strength
Current Ratio (mrq)9.96 
Debt/Equity (mrq)0.00 
Total Cash (mrq)$147.3M
Short Interest
As of 8-Aug-2001
Shares Short663.0K
Percent of Float8.0%
Shares Short
(Prior Month)
500.0K
Short Ratio5.87 
Daily Volume113.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.